A.I. Case Studies (Exit Support) - Health Business Group

CDMO Due Diligence: Pinpointing Opportunity in a Complex Market

Li Wang — Sun, 14 Dec 2025 14:04:44 +0000

Client Type: Real-estate investor evaluating entry into pharmaceutical contract manufacturing

Challenge:
The investor signed a letter of intent to acquire a fast-growing contract development and manufacturing organization (CDMO) but lacked sector experience. They needed to validate market attractiveness, customer stickiness, and management strength before closing.

Approach:
HBG structured diligence around key hypotheses: demand drivers, outsourcing trends, customer relationships, and competitive positioning. We gathered data through interviews with customers, experts, and competitors, augmented with industry reports and HBG benchmarks.

Impact:
The analysis clarified market dynamics, identified strengths and red flags, and informed negotiation strategy. Our findings gave the investor confidence to proceed on refined terms that better reflected risk.

Why It Matters:
In life-sciences manufacturing, detailed expertise is required to identify the right assets and focus areas. HBG helps investors see what insiders know.

Thumbnail Summary: A real-estate investor exploring life-sciences manufacturing relied on HBG’s commercial diligence to validate market dynamics, customer stickiness, and competitive positioning.

SEO Meta Description: HBG’s due diligence helped an investor understand CDMO market trends and make informed investment decisions.

CCM/RPM Diligence: Testing Investment Thesis Under Regulatory Uncertainty

Li Wang — Sun, 14 Dec 2025 14:04:19 +0000

Client Type: Middle-market private equity firm

Challenge:
A potential acquisition in chronic care management and remote monitoring showed promise but came with reimbursement and policy risk. The investor needed clarity on sustainability and growth levers before bidding.

Approach:
HBG analyzed market size and growth by payer and provider type, interviewed customers, competitors, and experts, and partnered with a healthcare law firm to assess regulatory outlooks. We built a microeconomic model to simulate profitability under multiple reimbursement scenarios.

Impact:
The analysis revealed that base-case assumptions were overly optimistic and highlighted hidden downside risk. The investor adjusted course and avoided overpaying, while identifying strategic shifts that could make the target viable in future.

Why It Matters:
Policy changes can make or break healthcare investments. HBG brings grounded analysis that turns uncertainty into informed decision-making.

Thumbnail Summary: HBG’s rigorous market and policy analysis helped a private equity firm test its investment thesis, uncover hidden risks, and avoid overpaying for a CCM/RPM platform in a shifting reimbursement landscape.

SEO Meta Description: HBG conducted diligence for a PE firm on CCM and RPM investments, identifying risks and regulatory impacts.

Temperature-Controlled Packaging: Positioning for a Successful Exit

Li Wang — Sun, 14 Dec 2025 14:03:46 +0000

Client Type: PE-backed logistics and packaging company preparing for sale

Challenge:
Evolving environmental standards and pandemic-driven vaccine transport created volatility in the temperature-controlled packaging market. The company needed an independent market study to educate buyers and strengthen its sale narrative.

Approach:
HBG developed hypotheses on demand drivers, materials innovation, and competitive positioning. Through 40 market interviews and extensive secondary research, we built a detailed model of market size, growth, and regulatory impact. We prepared a comprehensive, buyer-ready package and participated in Q&A with bidders.

Impact:
The study enhanced management’s credibility and expanded buyer interest. The company achieved a sale valuation that exceeded sponsor expectations and was the firm’s top investment return ever.

Why It Matters:
Independent market insight builds confidence and value. HBG’s sector depth helps clients communicate complexity simply and achieve stronger outcomes.

Thumbnail Summary: For a PE-backed logistics firm preparing for sale, HBG conducted a market study that clarified growth drivers and boosted buyer confidence. The ultimate valuation exceeded client’s expectations.

SEO Meta Description: HBG produced an independent market study that enhanced valuation for a PE-backed packaging firm’s sale.

Temperature-Controlled Packaging: From Diligence Insight to Market Expansion Strategy

Li Wang — Sun, 14 Dec 2025 14:03:07 +0000

Client Type: Private-equity–backed supplier of reusable temperature-controlled packaging

Challenge

When a private-equity investor considered acquiring an innovative supplier of reusable temperature-controlled packaging (TCP), they turned to HBG for commercial diligence. The deal team needed to validate market growth, competitive positioning, and regulatory and pharmaceutical-industry risks before proceeding.

After closing the investment, the sponsor and management sought additional support to evaluate new opportunities arising from the GLP-1 weight-loss drug boom, particularly demand for cold-chain parcel packaging in direct-to-consumer (DTC) distribution.

Approach

Phase 1 – Commercial Diligence

HBG conducted a rapid yet comprehensive market assessment to quantify market size and growth, benchmark competitors, and identify emerging trends in reusable packaging. The team performed deep secondary research, reviewed trade and regulatory sources, and completed over 20 interviews with buyers, logistics companies, and industry experts to test demand assumptions and competitive differentiation. The diligence highlighted tailwinds including sustainability trends and pharma-logistics expansion and headwinds, such as industry consolidation and tightening regulations on single-use plastics.

Phase 2 – GLP-1 Market Opportunity Assessment

Following a successful transaction, HBG re-engaged to help the company capture growth from the surging GLP-1 market. The study mapped the U.S. and European ecosystems of DTC/DTP telehealth providers, pharma manufacturers, pharmacies, compounders, and logistics partners; estimated parcel-shipper TAM driven by GLP-1; and identified unmet needs in packaging performance and sustainability.

Impact

Investment confidence: The initial diligence provided a robust, evidence-based foundation for investment approval.
Growth acceleration: The follow-on study defined a clear go-to-market path into the fast-growing direct-to-patient cold-chain segment, positioning the company as a preferred supplier to major DTC brands.
Strategic alignment: The two-phase engagement demonstrated continuity from diligence to execution, strengthening trust between investor, management, and HBG.

Why It Matters

The engagement demonstrates how post-diligence collaboration can extend deal value. By combining transaction-level insight with operational strategy, HBG helps investors and portfolio companies turn diligence findings into sustainable growth.